Financial Times/Deloitte Global Pharmaceutical & Biotechnology Conference
Financial Times/Deloitte Digital Health Summit USA
Pharma and the connected patient
How digital technology is enabling patient centricity
New research released by the Deloitte UK Centre for Health Solutions explores how digital technology can help pharma embrace patient centricity to remain relevant, profitable, and to deliver better health outcomes.
Under the spotlight
Data integrity in life sciences
Regulatory bodies now have high expectations with regard to data quality and integrity owing to the life sciences industry’s growth, globalization and adoption of advanced technology, such as highly automated systems and storage of data in ‘The Cloud’. Read the report to learn more.
High-value health care
Innovative approaches to global challenges
What are pioneering health care providers, health plans, and life science companies doing to anticipate patient needs, reduce costs, and improve overall health outcomes in the US and globally? Learn more in this new Deloitte Center for Health Solutions research.
Identification of Medicinal Products
Identification of Medicinal Products (IDMP) is one the biggest regulatory challenges for all pharmaceutical companies operating in Europe. How can your organisation navigate this journey towards increased patient safety and use it as an opportunity for business transformation?
Healthcare and Life Sciences Predictions 2020
Taxing times ahead
Tax is a hot topic right now for big business and will have major repercussions for the healthcare and life sciences industry. This paper explores the key tax challenges facing the industry and provides thought-provoking ideas to enable you to discuss future scenarios and how best to respond.
China's healthcare provider market